Total Raised

$4.3M

Investors Count

3

Deal Terms

1

Funding, Valuation & Revenue

3 Fundings

OticPharma has raised $4.3M over 3 rounds.

OticPharma's latest funding round was a Reverse Merger for on December 22, 2016.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/22/2016

Reverse Merger

$XXM

0

FY undefined

3

2/26/2012

Series A

$XXM

$XXM

0

FY undefined

10

Other Investors

$XXM

0

FY undefined

0

Date

12/22/2016

2/26/2012

Round

Reverse Merger

Series A

Other Investors

Amount

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

3

10

0

Start free trial
New call-to-action

OticPharma Deal Terms

1 Deal Term

OticPharma's deal structure is available for 1 funding round, including their Series A from February 26, 2012.

Round

Series A

Funding Date

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

Board Voting

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$XXM

$XXM

$XXM

$XXM

OticPharma Investors

3 Investors

OticPharma has 3 investors. Novus Therapeutics invested in OticPharma's Reverse Merger funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/22/2016

12/22/2016

1
Reverse Merger

Corporation

California

00/00/0000

00/00/0000

OrbiMed

Subscribe to see more

Venture Capital

New York

Pontifax

Subscribe to see more

Venture Capital

Israel

First funding

12/22/2016

00/00/0000

Last Funding

12/22/2016

00/00/0000

Investor

OrbiMed

Pontifax

Rounds

1
Reverse Merger

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Venture Capital

Location

California

New York

Israel

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.